Scott Kopetz

Scott Kopetz

Company: MD Anderson Cancer Center

Job title: Professor


Clinical Update on RAS Targeting In CRC 2:30 pm

Multiple clinical trials are ongoing in CRC to explore the efficacy of RAS targeting, with varying degrees of effica Mechanisms of adaptive resistance are prevalent, and preclinical studies can guide rational combinations Based on experience to date, combinations will be needed in most settings for CRC patientsRead more

day: Day Two Track F

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.